Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Country / region: Mexico Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20091
20101
20122
20131
20184
20192
20211
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting5
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
Hoffmann-La Roche3
AstraZeneca2
Bristol-Myers Squibb2
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran2
Abbott1
Daiichi Sankyo1
Exelixis1
Merck Sharp & Dohme LLC1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular18
Liver Neoplasms7
Neoplasms3
Carcinoma2
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Transitional Cell2
Adenocarcinoma1
Adenoma, Islet Cell1
Biliary Tract Neoplasms1
Breast Neoplasms1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.